Russian and Slovenian scientists develop new integrated cancer therapy
06 November 2014
Scientists from Russia’s Tomsk in Siberia and their colleagues from Slovenia have come up with a new cancer therapy believed to be “unrivaled” globally and preventing resistance in patients, the Russian news agency RIA Novosti reported. According to Academician Sergei Psakhye, the director of Tomsk’s Institute of Strengths Physics and Materials Science (ISPMS) whose words were quoted in the news, the researchers have learned how to inhibit the growth and multiplication of cancerous cells, using a special material.
New antiviral drug to go into production in Urals
14 October 2014
A new antiviral drug called “Triasavirin” is expected to soon be put into production in the Urals; the biotech solution is believed to be based on an innovative technology of directly impacting a virus, the Skolkovo Foundation website reported . The Ural Center for Biopharma Technologies (UCBT), the developer of the solution, is a Skolkovo resident.
Ministry of Industry and explained what restrictions affect foreign PM
15 September 2014
Ministry of Industry and Trade has explained its position on foreign medicines, whose participation in the public procurement plan to cap. Developed a draft resolution will help the Ministry of Industry in 2018 90% of the domestic market to provide domestic medicines.
Russia does not plan to ban drug imports from Western countries
15 September 2014
The Russian government has no plans to impose a ban on the pharmaceutical imports from the European Union and the USA, as proposed by some local top-officials, as a response to the next package of sanctions against Russia, which was yesterday approved by the EU. According to Russian Prime Minister Dmitry Medvedev, such a measure is currently considered as destructive.
Russia to expand cooperation in healthcare with BRICS countries
12 September 2014
Deputy Foreign Minister Sergei Ryabkov says Russia had transformed from being a recipient of international assistance in healthcare into one of the largest donors
04 September 2014
Clearside Biomedical, Inc., announces the U.S. Patent and Trademark Office (USPTO) granted U.S. Patent Application No. 13/447,246 as U.S. Patent No. 8,808,225 in a patent titled, "Methods and Devices for Drug Delivery to Ocular Tissue Using Microneedle." This is the fourth patent allowance in the U.S. related to its proprietary microneedle drug delivery methods and devices.
Clearside Biomedical, Inc. Completes $16 Million Series B Financing
01 September 2014
Clearside Biomedical, Inc., today announced the closing of a $16 million Series B financing. The financing included new investor RusnanoMedInvest (RMI) and existing investors Hatteras Venture Partners, Santen Pharmaceuticals Co. Ltd., Mountain Group Capital and Georgia Research Alliance Venture Fund.
Russian Scientists Develop Method for Earlier Detection of Cancer
01 September 2014
Scientists from a subsidiary of the SIGMA.Novosibirsk nanotechnology center, a project run by the state-owned RUSNANO Corporation, have developed a technology that detects cancer in very early stages and can be employed at outpatient clinics, said a Friday statement on the center’s website.
New eye implant could replace glasses
26 August 2014
Reading glasses may become a thing of the past as a new implant revolutionises treatment for ageing eyes.
Implant means end of reading glasses is in sight
26 August 2014
Scientists have developed a tiny implant, no bigger than a pinhead, which sits inside the cornea and slightly increases its curvature, to allow the eye to focus again.
NovaMedica expands its line of products for the treatment of Alzheimer’s disease
22 August 2024
Children visited the NovaMedica Innotech pharmaceutical manufacturing facility
14 June 2024
16 May 2024
06 September 2024
HPV vaccine is to be included in Russia’s national immunization schedule by 2026
06 September 2024
New WHO guidance to support manufacturers to reduce AMR risk
05 September 2024
05 September 2024